Innate Pharma SA
1.9300
30-April-25 11:15:40
15 minutes delayed
Stocks
+0.1020
+5.58%
Today's range
1.9000 - 2.0100
ISIN
FR0010331421
Source
Cboe
-
Innate Pharma to Hold its Annual General Meeting of Shareholders on May 28, 2021
21 Apr 2021 01:00:00 By Nasdaq GlobeNewswire
-
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF APRIL 1, 2021
19 Apr 2021 01:00:00 By Nasdaq GlobeNewswire
-
Innate Pharma reports Full Year 2020 financial results and business update
18 Mar 2021 02:00:00 By Nasdaq GlobeNewswire
-
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
16 Mar 2021 02:00:00 By Nasdaq GlobeNewswire
-
Number of shares and voting rights of Innate Pharma as of February 1, 2021
24 Feb 2021 01:00:00 By Nasdaq GlobeNewswire
-
Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare Conference
17 Feb 2021 01:00:00 By Nasdaq GlobeNewswire
-
Innate Pharma advances lacutamab clinical development program
09 Feb 2021 01:00:00 By Nasdaq GlobeNewswire
-
03 Feb 2021 01:00:00 By Nasdaq GlobeNewswire
-
Innate's first NK cell engager selected by Sanofi as drug candidate for development
05 Jan 2021 01:00:00 By Nasdaq GlobeNewswire
-
Innate Pharma to participate in upcoming investor conferences
04 Jan 2021 01:00:00 By Nasdaq GlobeNewswire